no statement of use filed
on 23 Jul 2018
Last Applicant/ Owned by
1 DNA WAY
SOUTH SAN FRANCISCO
CA
94080
Serial Number
87260401 filed on 07th Dec 2016
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of white letters "ignyta" where the letter "t" is topped with the color red, with a blue background. House mark for pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders The color(s) blue, white, and red is/are claimed as a feature of the mark. Pharmaceutical research and devRead More
House mark for pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders
Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research in the fields of treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders
No 87260401
No Service Mark
No
No
No
No
No
No
No
No
No
The mark consists of white letters "ignyta" where the letter "t" is topped with the color red, with a blue background.
| Status Date | Action Taken |
|---|---|
| 22nd Aug 2018 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 23rd Jul 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 23rd Jul 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| 15th May 2018 | WITHDRAWAL OF ATTORNEY GRANTED |
| 15th May 2018 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| 16th Sep 2017 | CORRECTED NOA E-MAILED |
| 16th Sep 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Sep 2017 | EXTENSION 1 GRANTED |
| 15th Sep 2017 | DIVISIONAL PROCESSING COMPLETE |
| 31st Aug 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
